MIF and sarcoma: Along the same line, Tessaro et al. used a WT and an MIF-silenced sarcoma cell line for in vivo tumor growth, showing that the tumors from the MIF-silenced group were more prominently infiltrated by CD45+ hematopoietic cells, with a particular enrichment of monocytes and CD4+ T cells.